Product NDC: | 54868-5020 |
Proprietary Name: | Neupogen |
Non Proprietary Name: | filgrastim |
Active Ingredient(s): | 300 ug/.5mL & nbsp; filgrastim |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 54868-5020 |
Labeler Name: | Physicians Total Care, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA103353 |
Marketing Category: | BLA |
Start Marketing Date: | 20040311 |
Package NDC: | 54868-5020-0 |
Package Description: | 10 SYRINGE in 1 BOX (54868-5020-0) > .5 mL in 1 SYRINGE |
NDC Code | 54868-5020-0 |
Proprietary Name | Neupogen |
Package Description | 10 SYRINGE in 1 BOX (54868-5020-0) > .5 mL in 1 SYRINGE |
Product NDC | 54868-5020 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | filgrastim |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20040311 |
Marketing Category Name | BLA |
Labeler Name | Physicians Total Care, Inc. |
Substance Name | FILGRASTIM |
Strength Number | 300 |
Strength Unit | ug/.5mL |
Pharmaceutical Classes | Granulocyte Colony-Stimulating Factor [Chemical/Ingredient],Granulocyte-Macrophage Colony-Stimulating Factor [Chemical/Ingredient],Increased Myeloid Cell Production [PE],Leukocyte Growth Factor [EPC] |